1 Department of General Practice and Health Services Research, University Medical Hospital, Heidelberg, Germany 2 Department of Psychosomatic Medicine, University Medical Hospital Tübingen, Germany 3 ...

Hôpital Claude Huriez, Centre Hospitalier Universitaire de Lille, Lille, France Objective: To evaluate the efficacy of adalimumab in the healing of draining fistulas in patients with active Crohn’s ...

Background: Antibodies to soluble liver antigen/liver pancreas (SLA/LP) are specific markers of autoimmune hepatitis. Their target antigen has recently been cloned. Aims: To establish standardised ...

Inflammatory bowel disease and Parkinson’s disease are chronic progressive disorders that mainly affect different organs: the gut and brain, respectively. Accumulating evidence has suggested a ...

1 Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands 2 Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, ...

1 Faculty of Health Sciences, The Shraga Segal Department of Microbiology and Immunology and The Cancer Research Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel 2 Department of ...

Background Immune checkpoint inhibitors (ICIs) enable successful hepatocellular carcinoma (HCC) downstaging or bridging for ...

1 Department of Gastroenterology, Hvidovre University Hospital, Faculty of Health Sciences, Copenhagen University, Hvidovre, Copenhagen, Denmark 2 Department of Internal Medicine, Copenhagen ...

Correspondence to Professor Michelangelo Foti, Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva 1205, Switzerland; michelangelo.foti{at}unige.ch ...

Department of Psychosomatic Medicine, Kyushu University, Fukuoka, Japan. Fifty nine patients admitted with a diagnosis of psychogenic vomiting were classified into five patterns of vomiting: ...

Background and aims A general dysbiosis of the intestinal microbiota has been established in patients with Crohn's disease (CD), but a systematic characterisation of this dysbiosis is lacking.

Objective To monitor trastuzumab resistance and determine the underlying mechanisms for the limited response rate and rapid emergence of resistance of HER2+ metastatic gastric cancer (mGC). Design ...